ad image

Q22022

1 / 2
Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future
Pharma 4.0

Applying an Advanced Pharma 4.0 Perspective to Design the Facility of the Future

Yuk Chun Chiu, M.S.E.; Dawn Wofford; Patricia Robbins; Yvonne Duckworth; Steve Attig

Wheeler Bio

PAO-06-022-CL-11Sep 08, 2022
CAR-T Study Shines New Spotlight on Clinical Trials Representation
Column: Clinical Trials

CAR-T Study Shines New Spotlight on Clinical Trials Representation

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-022--NI-06Jul 02, 2022
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

PAO-06-022--NI-12Jun 24, 2022
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
Column: New Drug Watch

New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-022--NI-08Jun 24, 2022
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Column: Investment

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-02Jun 24, 2022
The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative
Column: Regulatory Spotlight

The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-022--NI-05Jun 24, 2022
Digital Frontiers: What NFTs Can Do for Pharma
NFTs

Digital Frontiers: What NFTs Can Do for Pharma

Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-01Jun 24, 2022
Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time
Column: Supply Chain

Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time

Tonia Becker

Nice Insight

PAO-06-022--NI-09Jun 24, 2022
Mental Health During a Global Pandemic
Mental Health

Mental Health During a Global Pandemic

Marc Technow

Nice Insight

PAO-06-022--NI-03Jun 24, 2022
10 More Biotechs Making Moves in 2022
Biotechs

10 More Biotechs Making Moves in 2022

David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

PAO-06-022--NI-07Jun 24, 2022
Taking Adoptive Cell Therapies to the Next Level
Cell Therapy

Taking Adoptive Cell Therapies to the Next Level

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-022--NI-04Jun 24, 2022
Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management
Quantum Computing

Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-022--NI-10Jun 24, 2022
Small Molecule API Market Trends
API

Small Molecule API Market Trends

James Grote

Nice Insight

PAO-06-022--NI-11Jun 24, 2022
Guide to Resource Recovery for Fortune 500 Companies
Used Equipment

Guide to Resource Recovery for Fortune 500 Companies

Julie Meno

Federal Equipment Company

PAO-04-022-CL-08Jun 24, 2022
Gaining Insights into the Challenges, Trends, and Needs of Animal Health Organizations
Animal Health

Gaining Insights into the Challenges, Trends, and Needs of Animal Health Organizations

Jeremy Tatum

TriRx Pharmaceutical Services

PAO-06-022-CL-10Jun 21, 2022
Real-World Data and Artificial Intelligence are Transforming Clinical Development
Real-World Data

Real-World Data and Artificial Intelligence are Transforming Clinical Development

Jeff Elton, Ph.D.

ConcertAI

PAO-06-022-CL-09Jun 21, 2022
Staying Agile to Bring Therapies to Patients with Rare Diseases
Rare Diseases

Staying Agile to Bring Therapies to Patients with Rare Diseases

Sheila Frame

Amryt Pharma

PAO-06-022-CL-08Jun 21, 2022
Meeting the Needs of the Evolving Sterile Injectables Market
Steriles

Meeting the Needs of the Evolving Sterile Injectables Market

Andrea Baiocchi; Marco Scanziani

Avara Pharmaceutical Services

PAO-06-022-CL-06Jun 16, 2022
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
Cell Therapy

Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner

Mark Shlomchik, M.D., Ph.D.

BlueSphere Bio

PAO-06-022-CL-03Jun 06, 2022
Tackling Liver Disease with a Multimodal Cyclophilin Inhibitor
Liver Disease

Tackling Liver Disease with a Multimodal Cyclophilin Inhibitor

Robert Foster, Pharm.D., Ph.D.

Hepion Pharmaceuticals

PAO-06-022-CL-01Jun 02, 2022
1 / 2